scispace - formally typeset
X

Xiaoyan Jiang

Researcher at Tongji University

Publications -  209
Citations -  11393

Xiaoyan Jiang is an academic researcher from Tongji University. The author has contributed to research in topics: Myeloid leukemia & Stem cell. The author has an hindex of 40, co-authored 186 publications receiving 10162 citations. Previous affiliations of Xiaoyan Jiang include BC Cancer Agency & Harbin Medical University.

Papers
More filters
Patent

Medical consultation information service system and method

TL;DR: In this paper, a medical consultation server and a self-service terminal are established by adopting a mode of B/S (Browser/Server) network architecture in the system, and the medical server is connected with a hospital information system to acquire patient hospitalizing information corresponding to registered ID codes.
Journal ArticleDOI

Association of BNP with Frailty in Elderly Population: Rugao Longevity and Ageing Study

TL;DR: Elevated plasma BNP was associated with increased risks of frailty, pre-frailty, and low levels of grip strength and gait speed in the elderly community people.
Journal ArticleDOI

Depressive symptoms are associated with incident frailty in a Chinese population: the Rugao Longevity and Aging Study.

TL;DR: Depressive symptoms are associated with prevalent and incident frailty in Chinese older population and together with the observations of the European populations, depressive symptoms may be a candidate risk factor of frailty.
Journal ArticleDOI

Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application

TL;DR: In this paper , the authors focused on the involvement of N6-methyladenosine (m6A) methylation in the dynamic evolution of tumor-adaptive TME and described the detailed mechanisms linking m6A methylation to change in tumor cell biological functions.
Journal ArticleDOI

Molecular mechanism of panaxydol on promoting axonal growth in PC12 cells

TL;DR: Compared with NGF and forskolin, panaxydol elicits axonal growth through the cAMP-Epac1-Rap1-MEK-ERK-CREB pathway, which is independent of PKA, and this suggests that Epac1 could mediate the axonalgrowth signaling pathway induced by panxydol.